我們已在上線! 進一步了解
IDXX圖示

Idexx Laboratories

560.36 USD
+13.18
2.41%
收盤時 已更新 10月16日 下午4:00 EDT
盤前交易
盤後交易
560.36
0.00
0%
1天
2.41%
5天
8.18%
1個月
9.1%
3個月
-2.73%
6個月
-1.68%
今年迄今
-16.36%
1年
-12.08%
5年
-12.21%
10年
403.6%
 

關於: Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

員工: 11,000

新聞

正面
中性
負面
市場情緒 3個月
正面 54.3%
中性 40%
負面 5.7%
中性
Business Wire
15 天前
IDEXX Laboratories to Release 2026 Third Quarter Financial Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 third quarter financial results for Monday, November 2, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q3 2026 Earnings Snapshot through a link on the IDEXX websi.
IDEXX Laboratories to Release 2026 Third Quarter Financial Results
中性
PRNewsWire
16 天前
Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories
Transaction marks the first realization from the now closed specialist animal health fund's inaugural vehicle CHICAGO, Sept. 30, 2026 /PRNewswire/ -- Chicago Pacific Founders ("CPF") today announced the exit of its investment in CoVetAI Inc. ("CoVet") following the company's acquisition by IDEXX Laboratories, Inc. (NASDAQ: IDXX).
Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories
中性
Zacks Investment Research
23 天前
Should You Continue to Hold IDXX Stock in Your Portfolio?
IDEXX's CAG growth, expanding software adoption and global gains face headwinds from FX and weaker U.S. vet visits.
Should You Continue to Hold IDXX Stock in Your Portfolio?
正面
MarketBeat
26 天前
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets
IDEXX Laboratories NASDAQ: IDXX executives highlighted the company's diagnostic innovation pipeline, recurring-revenue growth and commercial investments during the Morgan Stanley Global Healthcare Conference, while reaffirming confidence in its long-term growth framework despite continued pressure on veterinary office visits.
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets
正面
MarketBeat
26 天前
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference
IDEXX Laboratories NASDAQ: IDXX executives reiterated the company's long-term growth framework at the Morgan Stanley Global Healthcare Conference, citing demand for veterinary diagnostics, product innovation, commercial investments and recurring-revenue economics as key drivers.
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference
正面
Zacks Investment Research
29 天前
IDEXX Stock Gains Following the Acquisition of CoVet
IDXX shares rise 0.6% after the company acquires CoVet, expanding its AI-native software capabilities to improve veterinary workflows, diagnostics and practice performance.
IDEXX Stock Gains Following the Acquisition of CoVet
中性
Business Wire
29 天前
IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX expands Faecal Dx™ antigen testing platform in the United Kingdom with taeniid tapeworm detection for broader intestinal parasite screening.
IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection
中性
Business Wire
上個月
IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX announces acquisition of CoVetAI to advance veterinary workflow intelligence.
IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence
中性
Seeking Alpha
上個月
IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
正面
Seeking Alpha
上個月
Baron Partners Fund Q2 2026 Contributors And Detractors
Baron Partners Fund performed very well in the second quarter, gaining 16.61% (Institutional Shares). Top contributors include Space Exploration Technologies, Tesla, Red Rock Resorts, Hyatt Hotels and Birkenstock Holding. Top detractors include CoStar Group, Gartner, Guidewire Software, Morningstar and IDEXX Laboratories.
Baron Partners Fund Q2 2026 Contributors And Detractors
價格圖表採用Lightweight Charts™實作